Robotic assisted mediatinoscopic subtotal esophagectomy and three-field dissection for esophageal cancer

Robotic assisted mediatinoscopic subtotal esophagectomy and three-field dissection for esophageal cancer - Robotic assisted transhiatal radical esophagectomy

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000007450

Enrollment

Registered

2012-03-06

Start date

2012-03-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

esophageal cancer

Interventions

From approval to the 31st, March/2014 Non thoracic, transhiatal esophagectomy with three-field radical lymphadenectomy for esophageal cancer

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Curable thoracic esophageal and/or gastroesophageal junctional cancer

Exclusion criteria

Exclusion criteria: Tumor invading adjacent organ Prior chemoradiotherapy Abnormal laboratory findings (CRP>10,WBC>15000)

Design outcomes

Primary

Measure	Time frame
intraoperative blood loss duration of operation surgical morbidity	—

Secondary

Measure	Time frame
number of harvested lymph nodes length of postoperative hospital stay disease free survival	—

Countries

Japan

Contacts

Public ContactKazuhiko Mori

the University of Tokyo Hospital Gastrointestinal Surgery

morikaz158@gmail.com03-3815-5411

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026